Research programme: Ibogaine analogues - Gilgamesh Pharmaceuticals
Alternative Names: GM-300X; Ibogaine analogues - Gilgamesh PharmaceuticalsLatest Information Update: 30 Mar 2023
At a glance
- Originator Gilgamesh Pharmaceuticals
- Class Drug withdrawal therapies; Indoles; Rauwolfia alkaloids; Small molecules
- Mechanism of Action Excitatory amino acid antagonists; Opioid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Opioid-related disorders